Adolescent Obesity: Clinical Trials

4 trials for Adolescent Obesity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting. 4 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Active not recruiting 1
Phase 12Active not recruiting 1, Completed 1
Phase 31Completed 1

Follow Adolescent Obesity: new trials by email Literature Review of Adolescent Obesity trials Research Report on Adolescent Obesity

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SMART Use of Medication for the Treatment of Adolescent Severe Obesity
Lifestyle Modification Therapy (LSMT), Phentermine Pill, Topiramate Pill - Adolescent Obesity
Phase 2CompletedUniversity of Minnesota1502019-11-212026-05-05
Treating PCOS With Semaglutide vs Active Lifestyle Intervention
Semaglutide 3mg and 7mg [Rybelsus], Weight loss diet - PCOS, Adolescent Obesity
Phase 2 / Phase 3CompletedUniversity of Colorado, Denver602019-05-032025-11-25
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study
Aminohippurate Sodium Inj 20%, Iohexol Inj 300 MG/ML, Renal Biopsy - Type 2 Diabetes Mellitus, Obesity
Phase 1 / Phase 2Active not recruitingUniversity of Colorado, Denver1002018-10-012023-08-15
Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
Aminohippurate Sodium Inj 20%, Iohexol Inj 300 mg/mL, Vertical Sleeve Gastrectomy - Type 2 Diabetes Mellitus, Obesity
Phase 1 / Phase 2CompletedUniversity of Colorado, Denver242018-10-012026-01-12

Narrower conditions

Pediatric Obesity (4)  ·  Diabetes Mellitus, Type 2 (2)  ·  Kidney Diseases (2)  ·  Obesity (2)  ·  Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Diabetic Nephropathies (1)  ·  Insulin Resistance (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Weight Loss (1)

Broader conditions

Body Weight (4)  ·  Nutrition Disorders (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Overnutrition (4)  ·  Overweight (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Glucose Metabolism Disorders (3)  ·  Metabolic Diseases (3)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Male Urogenital Diseases (2)  ·  Obesity (2)  ·  Urogenital Diseases (2)

Interventions

Iohexol (2)  ·  p-Aminohippuric Acid (2)  ·  Bariatric Surgery (1)  ·  Diet, Reducing (1)  ·  Phentermine (1)  ·  Topiramate (1)  ·  semaglutide (1)

Sponsors

University of Colorado, Denver (3)  ·  University of Minnesota (1)

Countries

United States (4)

Top investigators

Petter Bjornstad, MD (2)  ·  Claudia Fox, MD, MPH (1)  ·  Melanie Cree-Green, MD, PhD (1)

Results publications

PMID 32737116, PMID 35507146, PMID 41708511, PMID 42014131

NIH funding

R01DK119456 (1), R01DK120612 (1)